GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Petlife Pharmaceuticals Inc (OTCPK:PTLF) » Definitions » 14-Day RSI

Petlife Pharmaceuticals (Petlife Pharmaceuticals) 14-Day RSI : N/A (As of May. 30, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Petlife Pharmaceuticals 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-05-30), Petlife Pharmaceuticals's 14-Day RSI is N/A.

The industry rank for Petlife Pharmaceuticals's 14-Day RSI or its related term are showing as below:

PTLF's 14-Day RSI is not ranked *
in the Drug Manufacturers industry.
Industry Median: 45.355
* Ranked among companies with meaningful 14-Day RSI only.

Competitive Comparison of Petlife Pharmaceuticals's 14-Day RSI

For the Drug Manufacturers - Specialty & Generic subindustry, Petlife Pharmaceuticals's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Petlife Pharmaceuticals's 14-Day RSI Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Petlife Pharmaceuticals's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Petlife Pharmaceuticals's 14-Day RSI falls into.



Petlife Pharmaceuticals  (OTCPK:PTLF) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Petlife Pharmaceuticals  (OTCPK:PTLF) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Petlife Pharmaceuticals 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Petlife Pharmaceuticals's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Petlife Pharmaceuticals (Petlife Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
38 West Main Street, 6th Floor, Hancock, MD, USA, 21750
Petlife Pharmaceuticals Inc specializes in the research, development, sales, and support of advanced drugs and nutraceuticals for pet cancer and autoimmune related diseases such as arthritis. It develops potentiated veterinary cancer medications and nutraceuticals, under its tradename Vitalzul based on Escozine formula. The Vitalzul is a polarized, bioactive peptide extracted from the Blue Caribbean Scorpion (Rhopularus Princeps), which contains amino acids, proteins, and minerals.
Executives
Randy Steven White director, 10 percent owner, officer: President/Secretary/Treasurer OPLETALOVA 43, PRAGUE 2N 11000

Petlife Pharmaceuticals (Petlife Pharmaceuticals) Headlines